Active hexose correlated compound (AHCC) is an oligosaccharide extracted from mushrooms grown in rice bran. It was developed in Japan in 1989 and it has since been used to improve the immunity of over 100 000 patients. AHCC has shown promise for severe immunodeficiencies, for hypertension, to reduce inflammation, to improve the body’s response to stress, in infections, for diabetics and for hepatitis.
AHCC is remarkable because it has the ability to stimulate the immune system. Oral supplementation with AHCC increases the production by immune cells of at least two protein messengers. These proteins promote the production of macrophages, T cells and natural killer (NK) cells and improve their ability to destroy abnormal cells. Immune cells are important for health in general but are specifically involved with the control of infection and cancer.
Why is it that when we get sick we direct the treatment on those pathogens and not on
improving our ability to fight and prevent disease. The great promise of immunotherapies lies in their ability to stimulate our defense systems. AHCC’s gift at improving immunity has been demonstrated - finally a treatment that focuses on health and not on the disease.
